Nucleic acids research · 2026
Accurate prediction of cohesin and RNA Polymerase II-associated chromatin interactions using convolutional neural networks.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abbas Ahmed, Chandratre Khyati, Liu Chengcheng, Zhang Michael Q, Mani Ram S
Аннотация
The three-dimensional (3D) genome organization specifies how the distal regulatory elements in the linear genome interact with target genes to regulate transcription. Several experimental methods have been developed to study the 3D genome organization. However, these methods are, in general, expensive, technically challenging, and time-consuming. We present Convolutional Neural Networks-Chromatin Interaction Predictor (CNN-ChIPr), a machine learning method for predicting the relative strength of cohesin- and RNA Polymerase II (RNA Pol II)-associated chromatin interactions/loops using experimental ChIP-seq data and other public inputs that can be easily obtained without additional new experiments. To leverage the pattern-recognition capability of CNN, we formatted the multiple ChIP-seq data, defining the features of interaction anchor regions into two-dimensional (2D) grids. The results showed that CNN-ChIPr performs well in predicting cohesin- and RNA Pol II-associated chromatin interactions at the peak-level resolution. The predictions can also be used to reconstruct contact maps with high similarity to the maps constructed by the original data. In addition to cohesin loops and RNA Pol II loops, CNN-ChIPr can accurately predict Hi-C interactions as well. We demonstrate the utility of this approach by identifying chromatin loops, target genes, and downstream pathways associated with enhancers regulated by the binding of tissue-specific master transcription factors, androgen receptor (AR) and estrogen receptor (ER), in prostate cancer and breast cancer cells, respectively. Collectively, CNN-ChIPr complements experimental 3D genome mapping technologies and provides a powerful alternative in contexts where such assays are impractical or infeasible, such as clinical specimens or time-course studies.